Ticker: IXHL

Incannex Healthcare Inc. (NASDAQ: IXHL) has released its latest quarterly financial report for the period ending March 31, 2025. Here are some crucial insights into its income statement and current company status: Key Financial Highlights: Net Loss: $15.3 million for the nine months ending March...

Incannex Healthcare Inc. (NASDAQ: IXHL) OverviewIncannex Healthcare Inc. operates in the biopharmaceutical sector focusing on developing combination medicines for chronic conditions. The company's ongoing projects include IHL-42X targeting obstructive sleep apnea (OSA), IHL-675A for inflammatory ...